The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...

Dr. Marty Makary, the Johns Hopkins surgeon and professor who, Trump tapped to lead the FDA, clarified the recently changed ...

Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...

The US Food and Drug Administration will meet its drug approval targets this year despite cutting thousands of staff, the ...

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.). “As with all drugs, FDA continues to ...

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

"Expert Panels with the FDA" are a series of roundtable discussions to provide an open public discourse on the latest medical and scientific information on several important topics. At this roundtable ...

Dr. Marty Makary, the Johns Hopkins surgeon and professor whom President Donald Trump tapped to lead the U.S. Food and Drug Administration, says it’s up to patients and their doctors whether ...

A recent study found that 11 percent of women experience an adverse effect from mifepristone, 22 times higher than its ...